AptarGroup, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Gael Touya
- Full Time Employees
- 14,000
- Sector
- Process industries
- Industry
- Containers/Packaging
- Address
- 265 Exchange Drive Crystal Lake IL United States 60014
- IPO Date
- Apr 23, 1993
- CIK
- 0000896622
- Website
- aptar.com
- Similar Companies
- Business
- AptarGroup, Inc. designs, manufactures and markets a broad range of drug delivery systems, consumer product dispensing systems, active material science solutions and sealing, packaging services for the pharmaceutical, beauty, personal care, home care, food and beverage industries worldwide. The company operates through three main segments: Aptar Pharma, which provides nasal and pulmonary drug delivery devices including pumps for nasal allergy treatments, metered-dose inhaler valves for respiratory conditions such as asthma and chronic obstructive pulmonary disease, elastomers for injectable packaging components, proprietary Unidose and Bidose intranasal delivery systems, aerosol valves, digital health solutions and clinical trial materials manufacturing services; Aptar Beauty, which offers dispensing pumps, closures, pouch spouts, spray pumps and valves for fragrance, make-up, skincare and cleansing products; and Aptar Closures, which supplies dispensing closures, dosing cups, droppers and other packaging solutions. AptarGroup sells its products primarily in North America, Europe, Asia and Latin America; the company was incorporated in 1992 and maintains headquarters in Crystal Lake, Illinois, with manufacturing facilities and over 13,000 employees across 20 countries. Recently, Aptar Pharma acquired the device technology assets of SipNose Nasal Delivery Systems in November 2025 to expand its intranasal drug delivery portfolio for local, systemic and central nervous system indications including nose-to-brain pathways; acquired clinical trial materials manufacturing capabilities of Mod3 Pharma in July 2025 to enhance Phase 1 and 2 formulation, fill-finish services for orally inhaled and nasal drug products at an FDA-inspected facility in Boonton, New Jersey; acquired Brazilian pharmaceutical packaging firm Sommaplast in December 2025 to strengthen oral dosing solutions such as closures, droppers, dispensers and dosing cups amid growth in over-the-counter and nutraceutical markets; issued approximately $600 million in senior unsecured notes due 2031 in November 2025 to bolster financial flexibility for operations and acquisitions; and extended collaboration with Nasus Pharma on intranasal epinephrine devices.
Company News
Rakovina Therapeutics to Present Brain-Penetrant ATR Inhibitor Data at the 31st Society for Neuro-Oncology Annual Meeting
Dividend Announcements: October 24-30, 2026 (Part 1 Of 2)
Investing in AptarGroup (ATR)? Don't Miss Assessing Its International Revenue Trends
Atrium Therapeutics to Present Nonclinical Data Showing ATR 1072 Reversed and Improved Features of PRKAG2 Syndrome During HCMS at AHA Scientific Sessions 2026
Aptar: 3 Key Takeaways for Long-Term Investors
Emerson Among 14 Dividend Growth Companies To Announce Annual Dividend Increases In First Half Of November
Dividend Champion, Contender, And Challenger Highlights: Week November 1
AptarGroup, Inc. (ATR) Q3 2026 Earnings Call Transcript
What AptarGroup (ATR) Said on Its Q3 Earnings Call
AptarGroup (ATR) Q3 Earnings and Revenues Beat Estimates
Aptar Reports Third Quarter 2026 Results
Aptar Increases Quarterly Dividend to $0.50 Per Share
Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program
AptarGroup, Inc. $ATR Stock Bought by State of Alaska Department of Revenue
AptarGroup, Inc. (ATR) – What Are Brokerages Saying About This Stock?
AptarGroup (ATR) Loses 5.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
3 Packaging Stocks Worth Watching Despite Industry Pressure
AptarGroup, Inc. $ATR Shares Sold by Tidal Investments LLC
VIRGINIA RETIREMENT SYSTEMS ET Al Buys New Holdings in AptarGroup, Inc. $ATR
AptarGroup, Inc. (ATR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript